International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“On a new episode of Lung Cancer Considered, Dr. Chunxia Su leads a Virtual Tumor Board discussion in Mandarin with Drs. Zhengfei Zhu and Nan Wu. Together, they explore key considerations in neoadjuvant and perioperative therapy for locally advanced NSCLC in China.
This episode is part of IASLC’s world language podcast series and brings expert insight to lung cancer treatment strategies in Mandarin.
More posts featuring IASLC on OncoDaily.